Archives
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Sulfo-NHS-Biotin: Precision Water-Soluble Protein Labeling
2026-02-04
Sulfo-NHS-Biotin revolutionizes cell surface protein labeling with water-soluble, amine-specific biotinylation—eliminating the need for organic solvents and enabling high-throughput, quantitative workflows. Its unique chemistry delivers unmatched selectivity and reproducibility, empowering advanced applications from phage diagnostics to single-cell proteomics.
-
TG003: Selective Clk Family Kinase Inhibitor for Alternat...
2026-02-04
TG003 empowers researchers to precisely modulate alternative splicing by selectively inhibiting key Clk family kinases. Its utility spans from dissecting splice site selection in cancer and neuromuscular models to enabling high-fidelity exon-skipping therapy workflows. Robust nanomolar potency and proven versatility make TG003 a gold-standard reagent for translational splicing research.
-
Protease Inhibitor Cocktail EDTA-Free: Precision in Prote...
2026-02-03
APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) streamlines protein extraction and analysis with robust, broad-spectrum inhibition—without interfering with phosphorylation studies. Discover how this specialized cocktail empowers advanced workflows across Western blotting, co-immunoprecipitation, and kinase assays, while minimizing troubleshooting headaches.
-
Sulfo-NHS-Biotin: Enabling Single-Cell Protein Profiling ...
2026-02-03
Explore how Sulfo-NHS-Biotin, a water-soluble biotinylation reagent, advances single-cell functional profiling and cell therapy innovation. This article delivers unique scientific insight into amine-reactive protein labeling within single-cell and immunotherapy workflows.
-
Strategic Protease Inhibition: Empowering Translational R...
2026-02-02
Discover how advanced protease inhibitor cocktails—specifically the EDTA-free, 200X DMSO formulation—are revolutionizing protein extraction, experimental reproducibility, and translational research. Grounded in mechanistic understanding and strategic best practices, this article delivers actionable guidance for researchers navigating the evolving landscape of protein science, from infection biology to post-translational modification analysis.
-
Harnessing E-64d for Precision Control of Cysteine Protea...
2026-02-02
E-64d, a membrane-permeable cysteine protease inhibitor, is revolutionizing research on apoptosis, platelet function, and neuroprotection. This thought-leadership article weaves together mechanistic insights, latest evidence—including evolutionary perspectives on lysosome-dependent cell death—and practical strategies for translational scientists. Explore how E-64d, available from APExBIO, provides an edge in dissecting complex cell death pathways and translating findings into clinical models.
-
Optimizing Protein Extraction: Protease Inhibitor Cocktai...
2026-02-01
This article offers practical, scenario-driven guidance for biomedical researchers using Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) (SKU K1007) in cell viability, proliferation, and cytotoxicity workflows. Drawing from validated protocols, literature, and comparative data, it demonstrates how SKU K1007 preserves protein integrity, enhances assay reproducibility, and supports sensitive downstream applications, with actionable strategies for real-world laboratory challenges.
-
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Co...
2026-01-31
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) provides robust, broad-spectrum inhibition of serine, cysteine, and acid proteases during protein extraction. This EDTA-free formulation ensures compatibility with phosphorylation analysis and divalent cation-dependent assays, making it an essential tool for protein degradation prevention in cell lysates. APExBIO's K1007 kit is benchmarked for stability, specificity, and workflow flexibility.
-
Precision in Cysteine Protease Inhibition: Strategic Guid...
2026-01-30
This thought-leadership article explores the pivotal role of E-64, an L-trans-epoxysuccinyl peptide cysteine protease inhibitor, in advancing mechanistic studies, optimizing translational workflows, and accelerating innovation in cancer and cell signaling research. Integrating recent literature, competitive insights, and best practices, the article offers actionable strategies and a visionary perspective for scientists seeking to harness the full translational potential of cysteine protease inhibition.
-
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Br...
2026-01-30
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) offers robust, broad-spectrum inhibition of serine, cysteine, acid, and aminopeptidase proteases during protein extraction workflows. This EDTA-free formulation preserves protein integrity for phosphorylation analysis and enzyme assays. It is a gold standard protein extraction protease inhibitor for researchers requiring maximal preservation of protein structure and function.
-
TG003 and the Next Frontier of Clk Kinase Inhibition: Str...
2026-01-29
TG003, a highly selective Cdc2-like kinase (Clk) family inhibitor, is redefining translational research in alternative splicing modulation and platinum-resistant cancer therapy. This article provides an integrated mechanistic overview, experimental validation, and strategic guidance for leveraging TG003 in preclinical workflows. Drawing on recent evidence of Clk2’s role in platinum resistance and the expanding toolkit for exon-skipping therapy, we map out how TG003 from APExBIO stands at the vanguard of splice site selection research, enabling breakthroughs in cancer and neuromuscular disease models.
-
Protease Inhibitor Cocktail EDTA-Free: Elevating Protein ...
2026-01-29
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) sets a new benchmark for protein extraction and downstream analysis, delivering robust protection against serine, cysteine, and acid proteases without compromising phosphorylation-sensitive workflows. Its optimized composition enables high-fidelity Western blotting, co-immunoprecipitation, and advanced post-translational modification studies, ensuring maximal protein integrity where it matters most.
-
TG003: Selective Clk Family Kinase Inhibitor for Alternat...
2026-01-28
TG003 is a highly potent and selective Cdc2-like kinase inhibitor, enabling precise modulation of alternative splicing through nanomolar inhibition of Clk1/2/4. Its competitive ATP binding and in vivo efficacy position it as an essential benchmark tool for splice site selection research and exon-skipping therapy development.
-
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): En...
2026-01-28
Unlock superior protein integrity with the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO). This article reveals advanced scientific insights into its mechanism, advantages, and application in phosphorylation analysis—offering a unique perspective on protease inhibition for demanding workflows.
-
Sulfo-NHS-Biotin: Precision Cell Surface Protein Labeling...
2026-01-27
Sulfo-NHS-Biotin stands out as a water-soluble, amine-reactive biotinylation reagent—empowering reliable, selective labeling of cell surface proteins. Its unique properties drive advanced workflows in affinity chromatography, immunoprecipitation, and single-cell secretome analysis, ensuring high specificity and reproducibility for translational and bench researchers alike.